LifeStance Health Gr Analyst Price Targets

Wall Street analyst price targets and consensus rating for LifeStance Health Gr (LFST).

Price Target Range — 12 Quarters

Analyst Consensus — 10 Analysts

8Buy

2Hold

Consensus RatingBuy# Analysts10Avg. Consensus PT$11Upside to Avg. PT-12.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 5, 2026	Keybanc	Steve Dechert	PT Raise	Overweight	$13→$15
Sep 10, 2026	Barclays	Peter Warendorf	PT Raise	Overweight	$13→$15
Sep 9, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$13→$15
Aug 19, 2026	BTIG	David Larsen	PT Raise	Buy	$16→$18
Aug 14, 2026	JP Morgan	Lisa Gill	PT Raise	Neutral	$9→$13
Aug 7, 2026	BTIG	David Larsen	PT Raise	Buy	$15→$16
Jul 24, 2026	BTIG	David Larsen	PT Raise	Buy	$12→$15
Jul 21, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$11→$13
Jul 14, 2026	Barclays	Peter Warendorf	PT Raise	Overweight	$9→$13
Jul 13, 2026	Keybanc	Steve Dechert	PT Raise	Overweight	$11→$13
Jun 5, 2026	Goldman Sachs	Scott Fidel	Initiate	Buy→Neutral	$9
May 14, 2026	JP Morgan	Lisa Gill	PT Raise	Neutral	$8→$9
May 8, 2026	BTIG	David Larsen	PT Raise	Buy	$11→$12
Mar 6, 2026	Barclays	Peter Warendorf	PT Raise	Overweight	$8→$9
Feb 26, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$9→$10
Feb 26, 2026	UBS	Kevin Caliendo	PT Raise	Buy	$10→$12
Feb 26, 2026	Keybanc	Scott Schoenhaus	PT Raise	Overweight	$8→$9
Feb 2, 2026	BTIG	David Larsen	PT Raise	Buy	$10→$11
Dec 12, 2025	BTIG	David Larsen	PT Raise	Buy	$9→$10
Dec 9, 2025	Barclays	Peter Warendorf	Initiate	Overweight	$8

Analyst Ratings News

PRO
Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15

Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15

Barclays analyst Peter Warendorf maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $15

Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $13 to $15.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $18

BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $16 to $18.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $13

JP Morgan analyst Lisa Gill maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $9 to $13.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $16

BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $15 to $16.

Benzinga Newsdesk

LifeStance Health Group Inc

LifeStance Health Gr Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15

PRO
Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15

PRO
Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $15

PRO
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $18

PRO
JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $13

PRO
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $16

People Also Watch

People Also Watch

LifeStance Health Group Inc

LifeStance Health Gr Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROKeybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15

PROBarclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15

PROCanaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $15

PROBTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $18

PROJP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $13

PROBTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $16

People Also Watch

People Also Watch

PRO
Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15

PRO
Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15

PRO
Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $15

PRO
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $18

PRO
JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $13

PRO
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $16